Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Segall

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Computer-Aided Molecular Design|January 13, 2011
Guiding effective decisions: an interview with Matthew Segall, CEO of Optibrium. Interview by Wendy A. WarrMatthew Segall
Drug Discovery Today|February 13, 2003
Smart high-throughput screeningMatthew Segall
Journal of Computer-Aided Molecular Design|December 14, 2011
Can we really do computer-aided drug design?Matthew Segall
Expert Opinion on Drug Discovery|May 6, 2014
Advances in multiparameter optimization methods for de novo drug designMatthew Segall
Journal of Computer-Aided Molecular Design|October 19, 2010
Making priors a priorityMatthew Segall, Andrew Chadwick
Future Medicinal Chemistry|June 8, 2011
The risks of subconscious biases in drug-discovery decision makingMatthew Segall, Andrew Chadwick
Drug Discovery Today|January 16, 2002
Early ADME/Tox studies and in silico screeningAlbert P Li, Matthew Segall
Drug Discovery Today|February 23, 2019
Capturing and applying knowledge to guide compound optimisationMatthew Segall, Tamsin Mansley, Peter Hunt, et al.
Future Medicinal Chemistry|January 19, 2017
Practical applications of matched series analysis: SAR transfer, binding mode suggestion and data point validationPeter Hunt, Matthew Segall, Noel O'Boyle, et al.
Current Opinion in Drug Discovery & Development|February 26, 2004
In silico prediction of ADME properties: are we making progress?Alan P Beresford, Matthew Segall, Michael H Tarbit
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Computer-Aided Molecular Design|January 13, 2011
Guiding effective decisions: an interview with Matthew Segall, CEO of Optibrium. Interview by Wendy A. WarrMatthew Segall
Drug Discovery Today|February 13, 2003
Smart high-throughput screeningMatthew Segall
Journal of Computer-Aided Molecular Design|December 14, 2011
Can we really do computer-aided drug design?Matthew Segall
Expert Opinion on Drug Discovery|May 6, 2014
Advances in multiparameter optimization methods for de novo drug designMatthew Segall
Journal of Computer-Aided Molecular Design|October 19, 2010
Making priors a priorityMatthew Segall, Andrew Chadwick
Future Medicinal Chemistry|June 8, 2011
The risks of subconscious biases in drug-discovery decision makingMatthew Segall, Andrew Chadwick
Drug Discovery Today|January 16, 2002
Early ADME/Tox studies and in silico screeningAlbert P Li, Matthew Segall
Drug Discovery Today|February 23, 2019
Capturing and applying knowledge to guide compound optimisationMatthew Segall, Tamsin Mansley, Peter Hunt, et al.
Future Medicinal Chemistry|January 19, 2017
Practical applications of matched series analysis: SAR transfer, binding mode suggestion and data point validationPeter Hunt, Matthew Segall, Noel O'Boyle, et al.
Current Opinion in Drug Discovery & Development|February 26, 2004
In silico prediction of ADME properties: are we making progress?Alan P Beresford, Matthew Segall, Michael H Tarbit
Pageof 2